Title : Pertuzumab, trastuzumab, and standard anthracycline- and taxane-based chemotherapy for the neoadjuvant treatment of patients with HER2-positive localized breast cancer (BERENICE): a phase II, open-label, multicenter, multinational cardiac safety study.

Pub. Date : 2018 Mar 1

PMID : 29253081






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Background: Anti-HER2 therapies are associated with a risk of increased cardiac toxicity, particularly when part of anthracycline-containing regimens. Anthracyclines erb-b2 receptor tyrosine kinase 2 Homo sapiens